- Overview
- Bayer Group
- Stock
- Bonds
- Reports
- Annual Stockholders’ Meeting 2019
- Events
- Inside Information
- News
- Investor News
- Press
- Archive
- Overview
- Investor News 2018
- Investor News 2017
- Investor News 2016
- Investor News 2015
- Investor News 2014
- Investor News 2013
- Investor News 2012
- Investor News 2011
- Investor News 2010
- Investor News 2009
- Investor News 2008
- Investor News 2007
- Investor News 2006
- Investor News 2005
- Investor News 2004
- Investor News 2003
- Investor News 2002
- Investor News 2001
- Investor News 2000
- Handouts
- Downloads
- Service
FY/Q4 2015 Investor Conference Call
Thursday, February 25, 2016
Start at approx. 2:00 p.m. CET (1:00 p.m. UTC)
Fiscal 2015:
Another record year for Bayer
Focus on the Life Sciences following the successful stock market flotation of Covestro / Substantial sales and earnings increases at HealthCare / Good business development at CropScience despite a weaker market environment / Covestro posts strong earnings improvement / Group sales increase to EUR 46,324 million (plus 12.1 percent / Fx & portfolio adj. plus 2.7 percent) / EBITDA before special items advances by 18.2 percent to EUR 10,266 million / EBIT improves by 15.8 percent to EUR 6,250 million / Net income increases 20.0 percent to EUR 4,110 million / Core earnings per share up 16.0 percent to EUR 6.83 / Forecast for 2016: further growth in sales and earnings moreAudio recording of the Investor conference call
(MP3 format)
Presentation charts | Download PDF collect (3 MB) |
Annual Report 2015 | OnlineApp (for mobile devices)Download PDF collect (12 MB) |
Q4 2015 Analyst and Investor Briefing | Download PDF collect (804 KB) |
Transcript | Download PDF collect (362 KB) |
FY/Q4 2015 All in One Package for Investors and Analysts All documents in one ZIP file | Download ZIP collect (16 MB) |
Restatements 2014 / 2015 due to Covestro | Download XLSX collect (189 KB) |